Contract A207_PO-0461814

The University of Virginia awarded a purchase order (A207_PO-0461814) to Eurofins Genomics LLC on July 24, 2026, for the procurement of synthetic oligonucleotide primers. The contract, valued at twenty-one dollars, encompasses four line items consisting of salt-free, 50-nucleotide molecular biology reagents. The ordered items include two forward primers (mq_Tnfsf9_FWD and mq_CD80_FWD) and two reverse primers (mq_Tnfsf9_REV and mq_CD80_REV), with unit prices ranging from five to five dollars and fifty cents per item. All materials are designated for delivery to Caroline Petranyi Riedstra at the University of Virginia in Virginia.

Eurofins Genomics LLC, the prime contractor, is supplying specialized genomic research reagents intended to support molecular biology applications, likely for quantitative real-time polymerase chain reaction (qRT-PCR) or similar gene expression analysis. The primers target tumor necrosis factor superfamily member 9 (Tnfsf9) and cluster of differentiation 80 (CD80) genes, indicating the contract supports immunological or oncological research initiatives at the University of Virginia. This purchase order represents a routine procurement of consumable research materials with a short-term performance timeline.